No one knows, but I would assume they would discuss the drug's benefits, target markets, and revenue predictions in the US and worldwide. Here is the quote from the PR and link to the PR:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.